FDA Inspection 1257757 — Antares Pharma, Inc.
The FDA completed an inspection of Antares Pharma, Inc. on January 16, 2025 in Minnetonka, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 16, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Minnetonka, MN (United States)